Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI
Edward A. Copelan*, Betty K. Hamilton, Belinda R. Avalos, Kwang Woo Ahn, Brian J. Bolwell, Xiaochun Zhu, Mahmoud D. Aljurf, Koen W. van Besien, Christopher N. Bredeson, Jean-Yves Cahn, Luciano J. Costa, Marcos J. de Lima, Robert Peter Gale, Gregory A. Hale, Joerg Halter, Mehdi Hamadani, Yoshihiro Inamoto, Rammurti T. Kamble, Mark R. Litzow, Alison W. LorenDavid I. Marks, Eduardo Olavarria, Vivek Roy, Mitchell Sabloff, Bipin N. Savani, Matthew Seftel, Harry C. Schouten, Celalettin Ustun, Edmund K. Waller, Daniel J. Weisdorf, Baldeep M. Wirk, Mary M. Horowitz, Mukta Arora, Jeff Szer, Jorge Cortes, Matt E. Kalaycio, Richard T. Maziarz, Wael Saber
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI'. Together they form a unique fingerprint.